Review

Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, 266071, China

Search for more papers by this author

Yan Zhang

**Author for correspondence:

E-mail Address: qdzhangyan01@163.com

https://orcid.org/0000-0002-7111-7164

Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, 266071, China

Department of Clinical Laboratory, Zibo Central Hospital, 54 Gongqingtuan Road, Zibo, 255036, China

Search for more papers by this author

Bing Luo

*Author for correspondence:

E-mail Address: qdluobing@163.com

Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, 266071, China

Search for more papers by this author

Published Online:5 Sep 2023https://doi.org/10.2217/fvl-2022-0201

View article

Abstract

N6-methyladenosine (m⁶A) modification is the most pervasive type of RNA epigenetic modification in eukaryotes and the most common type of posttranscriptional modification of mRNA. m⁶A modification is a dynamic reversible process that can affect gene expression and play a crucial role in mRNA metabolism and multiple biological processes, ranging from RNA processing, nuclear export and RNA translation to decay. Meanwhile, much evidence has shown that m⁶A methylation regulates the life cycle of viruses and inhibits or promotes the development of various viruses. However, the mechanism of m⁶A methylation in virus-associated tumors has not been fully elucidated. This review highlights the role of m⁶A modification in various viruses to help establish new approaches for treating related diseases.

Plain language summary

Genes contain the instructions that tell the body how to function and grow properly. When these instructions are interpreted, they are made into an intermediate called mRNA. mRNA can be modified to have different functions. A common type of modification, known as m⁶A modification, can change the body's response to viral infections. This article reviews the evidence for the relationship between m⁶A modification and viral genes. Understanding this could help to identify new ways to treat diseases caused by viruses.

Keywords:

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

1. Purta E, O'connor M, Bujnicki JM, Douthwaite S. YccW is the m⁵C methyltransferase specific for 23S rRNA nucleotide 1962. J. Mol. Biol. 383(3), 641–651 (2008).
Medline CASGoogle Scholar
2. Oerum S, Degut C, Barraud P, Tisne C. m¹A Post-Transcriptional Modification in tRNAs. Biomolecules 7(1), 20 (2017).
MedlineGoogle Scholar
3. Boccaletto P, Machnicka MA, Purta E et al. MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 46(D1), D303–D307 (2018).
Medline CASGoogle Scholar
4. Desrosiers RC, Friderici KH, Rottman FM. Characterization of Novikoff hepatoma mRNA methylation and heterogeneity in the methylated 5′ terminus. Biochemistry 14(20), 4367–4374 (1975).
Medline CASGoogle Scholar
5. Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc. Natl Acad. Sci. USA 71(10), 3971–3975 (1974).
Medline CASGoogle Scholar
6. Ke S, Alemu EA, Mertens C et al. A majority of m⁶A residues are in the last exons, allowing the potential for 3′UTR regulation. Genes Dev. 29(19), 2037–2053 (2015).
Medline CASGoogle Scholar
7. Dominissini D, Moshitch-Moshkovitz S, Schwartz S et al. Topology of the human and mouse m⁶A RNA methylomes revealed by m⁶A-seq. Nature 485(7397), 201–206 (2012).
Medline CASGoogle Scholar
8. Lee M, Kim B, Kim VN. Emerging roles of RNA modification: m(6)A and U-tail. Cell 158(5), 980–987 (2014).
Medline CASGoogle Scholar
9. Liu J, Yue Y, Han D et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat. Chem. Biol. 10(2), 93–95 (2014).
Medline CASGoogle Scholar
10. Ping XL, Sun BF, Wang L et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 24(2), 177–189 (2014).
Medline CASGoogle Scholar
11. Jia G, Fu Y, Zhao X et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7(12), 885–887 (2011).
Medline CASGoogle Scholar
12. Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell 169(7), 1187–1200 (2017).
Medline CASGoogle Scholar
13. Machnicka MA, Milanowska K, Osman Oglou O et al. MODOMICS: a database of RNA modification pathways–2013 update. Nucleic Acids Res. 41(Database issue), D262–D267 (2013).
Medline CASGoogle Scholar
14. Zhao BS, He C. “Gamete On” for m(6)A: YTHDF2 exerts essential functions in female fertility. Mol. Cell 67(6), 903–905 (2017).
Medline CASGoogle Scholar
15. Zhou J, Wan J, Gao X, Zhang X, Jaffrey SR, Qian SB. Dynamic m(6)A mRNA methylation directs translational control of heat shock response. Nature 526(7574), 591–594 (2015).
Medline CASGoogle Scholar
16. Pan Y, Ma P, Liu Y, Li W, Shu Y. Multiple functions of m(6)A RNA methylation in cancer. J. Hematol. Oncol. 11(1), 48 (2018).
MedlineGoogle Scholar
17. Lavi S, Shatkin AJ. Methylated simian virus 40-specific RNA from nuclei and cytoplasm of infected BSC-1 cells. Proc. Natl Acad. Sci. USA 72(6), 2012–2016 (1975).
Medline CASGoogle Scholar
18. Krug RM, Morgan MA, Shatkin AJ. Influenza viral mRNA contains internal N6-methyladenosine and 5′-terminal 7-methylguanosine in cap structures. J. Virol. 20(1), 45–53 (1976).
Medline CASGoogle Scholar
19. Sommer S, Salditt-Georgieff M, Bachenheimer S et al. The methylation of adenovirus-specific nuclear and cytoplasmic RNA. Nucleic Acids Res. 3(3), 749–765 (1976).
Medline CASGoogle Scholar
20. Tan B, Gao SJ. RNA epitranscriptomics: regulation of infection of RNA and DNA viruses by N(6)-methyladenosine (m(6) A). Rev. Med. Virol. 28(4), e1983 (2018).
MedlineGoogle Scholar
21. Wen J, Lv R, Ma H et al. Zc3h13 regulates nuclear RNA m(6)A methylation and mouse embryonic stem cell self-renewal. Mol. Cell 69(6), 1028–1038; e1026 (2018).
Medline CASGoogle Scholar
22. Knuckles P, Lence T, Haussmann IU et al. Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m(6)A machinery component Wtap/Fl(2)d. Genes Dev. 32(5-6), 415–429 (2018).
Medline CASGoogle Scholar
23. Patil DP, Chen CK, Pickering BF et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537(7620), 369–373 (2016).
Medline CASGoogle Scholar
24. Warda AS, Kretschmer J, Hackert P et al. Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs. EMBO Rep. 18(11), 2004–2014 (2017).
Medline CASGoogle Scholar
25. Wang X, Feng J, Xue Y et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature 534(7608), 575–578 (2016).
Medline CASGoogle Scholar
26. Wang P, Doxtader KA, Nam Y. Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol. Cell 63(2), 306–317 (2016).
Medline CASGoogle Scholar
27. Pendleton KE, Chen B, Liu K et al. The U6 snRNA m(6)A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention. Cell 169(5), 824–835; e814 (2017).
Medline CASGoogle Scholar
28. Little NA, Hastie ND, Davies RC. Identification of WTAP, a novel Wilms' tumour 1-associating protein. Hum. Mol. Genet. 9(15), 2231–2239 (2000).
Medline CASGoogle Scholar
29. Horiuchi K, Kawamura T, Iwanari H et al. Identification of Wilms' Tumor 1-associating Protein Complex and Its Role in Alternative Splicing and the Cell Cycle. J. Biol. Chem. 288(46), 33292–33302 (2013).
Medline CASGoogle Scholar
30. Horiuchi K, Kawamura T, Iwanari H et al. Identification of Wilms' tumor 1-associating protein complex and its role in alternative splicing and the cell cycle. J. Biol. Chem. 288(46), 33292–33302 (2013).
Medline CASGoogle Scholar
31. Zheng G, Dahl JA, Niu Y et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol. Cell 49(1), 18–29 (2013).
Medline CASGoogle Scholar
32. Li Z, Weng H, Su R et al. FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N(6)-Methyladenosine RNA Demethylase. Cancer Cell 31(1), 127–141 (2017).
MedlineGoogle Scholar
33. Dina C, Meyre D, Gallina S et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet. 39(6), 724–726 (2007).
Medline CASGoogle Scholar
34. Jia G, Yang CG, Yang S et al. Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett. 582(23-24), 3313–3319 (2008).
Medline CASGoogle Scholar
35. Tang C, Klukovich R, Peng H et al. ALKBH5-dependent m⁶A demethylation controls splicing and stability of long 3′-UTR mRNAs in male germ cells. Proc. Natl Acad. Sci. USA 115(2), E325–E333 (2018).
Medline CASGoogle Scholar
36. Gerken T, Girard CA, Tung YC et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318(5855), 1469–1472 (2007).
Medline CASGoogle Scholar
37. Fu Y, Jia G, Pang X et al. FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA. Nat. Commun. 4, 1798 (2013).
MedlineGoogle Scholar
38. Alarcon CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF. HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell 162(6), 1299–1308 (2015).
Medline CASGoogle Scholar
39. Xiao W, Adhikari S, Dahal U et al. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Mol. Cell 61(4), 507–519 (2016).
Medline CASGoogle Scholar
40. Hsu PJ, Zhu Y, Ma H et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 27(9), 1115–1127 (2017).
Medline CASGoogle Scholar
41. Huang H, Weng H, Sun W et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat. Cell Biol. 20(3), 285–295 (2018).
Medline CASGoogle Scholar
42. Wojtas MN, Pandey RR, Mendel M, Homolka D, Sachidanandam R, Pillai RS. Regulation of m(6)A Transcripts by the 3′–>5′ RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Mol. Cell 68(2), 374–387; e312 (2017).
Medline CASGoogle Scholar
43. Wang X, Lu Z, Gomez A et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505(7481), 117–120 (2014).
MedlineGoogle Scholar
44. Wang X, Zhao Boxuan S, Roundtree Ian A et al. N6-methyladenosine modulates messenger RNA translation efficiency. Cell 161(6), 1388–1399 (2015).
Medline CASGoogle Scholar
45. Shi H, Wang X, Lu Z et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 27(3), 315–328 (2017).
Medline CASGoogle Scholar
46. Xu C, Wang X, Liu K et al. Structural basis for selective binding of m⁶A RNA by the YTHDC1 YTH domain. Nature Chemical Biology 10(11), 927–929 (2014).
Medline CASGoogle Scholar
47. Klein R, Morohashi K, Sahara H et al. Cyclosporin A associated helicase-like protein facilitates the association of hepatitis C virus RNA polymerase with its cellular cyclophilin B. PLOS ONE 6(4), e18285 (2011).
MedlineGoogle Scholar
48. Du H, Zhao Y, He J et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat. Commun. 7, 12626 (2016).
Medline CASGoogle Scholar
49. Li A, Chen YS, Ping XL et al. Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation. Cell Res. 27(3), 444–447 (2017).
Medline CASGoogle Scholar
50. Roundtree IA, Luo GZ, Zhang Z et al. YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. Elife 6, e31311 (2017).
MedlineGoogle Scholar
51. Mao Y, Dong L, Liu XM et al. m(6)A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2. Nat. Commun. 10(1), 5332 (2019).
MedlineGoogle Scholar
52. Tanabe A, Tanikawa K, Tsunetomi M et al. RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated. Cancer Lett. 376(1), 34–42 (2016).
Medline CASGoogle Scholar
53. Meyer KD, Patil DP, Zhou J et al. 5′-UTR m(6)A Promotes Cap-Independent Translation. Cell 163(4), 999–1010 (2015).
Medline CASGoogle Scholar
54. Edupuganti RR, Geiger S, Lindeboom RGH et al. N(6)-methyladenosine (m(6)A) recruits and repels proteins to regulate mRNA homeostasis. Nat. Struct. Mol. Biol. 24(10), 870–878 (2017).
Medline CASGoogle Scholar
55. Epstein MA, Achong BG, Barr YM. Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet 1(7335), 702–703 (1964).
Medline CASGoogle Scholar
56. Bu W, Joyce MG, Nguyen H et al. Immunization with components of the viral fusion apparatus elicits antibodies that neutralize Epstein–Barr virus in B cells and epithelial cells. Immunity 50(5), 1305–1316; e1306 (2019).
Medline CASGoogle Scholar
57. Cohen JI. Epstein–Barr virus infection. N. Engl. J. Med. 343(7), 481–492 (2000).
Medline CASGoogle Scholar
58. Munz C. Latency and lytic replication in Epstein–Barr virus-associated oncogenesis. Nat. Rev. Microbiol. 17(11), 691–700 (2019).
Medline CASGoogle Scholar
59. Young LS, Rickinson AB. Epstein–Barr virus: 40 years on. Nat. Rev. Cancer 4(10), 757–768 (2004).
Medline CASGoogle Scholar
60. Ohga S, Nomura A, Takada H, Hara T. Immunological aspects of Epstein–Barr virus infection. Crit. Rev. Oncol. Hematol. 44(3), 203–215 (2002).
MedlineGoogle Scholar
61. Wu F, Cheng W, Zhao F, Tang M, Diao Y, Xu R. Association of N6-methyladenosine with viruses and related diseases. Virol J. 16(1), 133 (2019).
MedlineGoogle Scholar
62. Zheng X, Wang J, Zhang X et al. RNA m(6)A methylation regulates virus-host interaction and EBNA2 expression during Epstein–Barr virus infection. Immun. Inflamm. Dis. 9(2), 351–362 (2021).
Medline CASGoogle Scholar
63. Lang F, Singh RK, Pei Y, Zhang S, Sun K, Robertson ES. EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis. PLoS Pathog. 15(6), e1007796 (2019). •• The viral-encoded latent oncoprotein EBNA3C activated transcription of METTL14, and directly interacted with METTL14 to promote its stability.
Medline CASGoogle Scholar
64. Xia TL, Li X, Wang X et al. N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay. EMBO Rep. 22(4), e50128 (2021). •• m6A-modified EBV transcripts are recognized and destabilized by the YTHDF1 protein, which leads to the m6A-dependent suppression of EBV infection and replication.
Medline CASGoogle Scholar
65. Dai DL, Li X, Wang L et al. Identification of an N6-methyladenosine-mediated positive feedback loop that promotes Epstein–Barr virus infection. J. Biol. Chem. 296, 100547 (2021).
Medline CASGoogle Scholar
66. Liu L, Zhou Q, Xie Y, Zuo L, Zhu F, Lu J. Extracellular vesicles: novel vehicles in herpesvirus infection. Virol Sin. 32(5), 349–356 (2017).
Medline CASGoogle Scholar
67. Chang Y, Cesarman E, Pessin MS et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266(5192), 1865–1869 (1994).
Medline CASGoogle Scholar
68. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332(18), 1186–1191 (1995).
Medline CASGoogle Scholar
69. Soulier J, Grollet L, Oksenhendler E et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments]. Blood 86(4), 1276–1280 (1995).
Medline CASGoogle Scholar
70. Gunther T, Grundhoff A. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLOS Pathog. 6(6), e1000935 (2010).
MedlineGoogle Scholar
71. Ye F, Chen ER, Nilsen TW. Kaposi's Sarcoma-Associated Herpesvirus Utilizes and Manipulates RNA N(6)-Adenosine Methylation To Promote Lytic Replication. J. Virol. 91(16),e00466–17 (2017). • The blockage of m6A inhibited splicing of the pre-mRNA encoding the replication transcription activator (RTA), a key KSHV lytic switch protein, and halted viral lytic replication.
Medline CASGoogle Scholar
72. Hesser CR, Karijolich J, Dominissini D, He C, Glaunsinger BA. N6-methyladenosine modification and the YTHDF2 reader protein play cell type specific roles in lytic viral gene expression during Kaposi's sarcoma-associated herpesvirus infection. PLoS Pathog. 14(4), e1006995 (2018). • The m6A pathway is centrally involved in regulating KSHV gene expression, and underscore how the outcome of this dynamically regulated modification can vary significantly between cell types.
MedlineGoogle Scholar
73. Baquero-Perez B, Antanaviciute A, Yonchev ID, Carr IM, Wilson SA, Whitehouse A. The Tudor SND1 protein is an m(6)A RNA reader essential for replication of Kaposi's sarcoma-associated herpesvirus. Elife 8, e47261 (2019).
Medline CASGoogle Scholar
74. Tan B, Liu H, Zhang S et al. Viral and cellular N(6)-methyladenosine and N(6),2′-O-dimethyladenosine epitranscriptomes in the KSHV life cycle. Nat. Microbiol. 3(1), 108–120 (2018).
Medline CASGoogle Scholar
75. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Control of cccDNA function in hepatitis B virus infection. J. Hepatol. 51(3), 581–592 (2009).
Medline CASGoogle Scholar
76. Beck J, Nassal M. Hepatitis B virus replication. World Journal of Gastroenterology 13(1), 48–64 (2007).
Medline CASGoogle Scholar
77. Imam H, Khan M, Gokhale NS et al. N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle. Proc. Natl Acad. Sci. USA 115(35), 8829–8834 (2018).
Medline CASGoogle Scholar
78. Kim GW, Imam H, Siddiqui A. The RNA binding proteins YTHDC1 and FMRP regulate the nuclear export of N(6)-methyladenosine-modified hepatitis B virus transcripts and affect the viral life cycle. J. Virol. 95(13), e0009721 (2021).
MedlineGoogle Scholar
79. Qu S, Jin L, Huang H, Lin J, Gao W, Zeng Z. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis. BMC Cancer 21(1), 686 (2021).
Medline CASGoogle Scholar
80. Kim GW, Siddiqui A. Hepatitis B virus X protein recruits methyltransferases to affect cotranscriptional N6-methyladenosine modification of viral/host RNAs. Proc. Natl Acad. Sci. USA 118(3), e2019455118 (2021). • HBx interacts with METTL3 and 14 to carry out methylation activity and also modestly stimulates their nuclear import.
Medline CASGoogle Scholar
81. Imam H, Kim GW, Mir SA, Khan M, Siddiqui A. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts. PLOS Pathog. 16(2), e1008338 (2020).
Medline CASGoogle Scholar
82. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136(5), E359–E386 (2015).
Medline CASGoogle Scholar
83. Jung KW, Won YJ, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res. Treat 51(2), 417–430 (2019).
MedlineGoogle Scholar
84. Wang X, Li Z, Kong B et al. Reduced m(6)A mRNA methylation is correlated with the progression of human cervical cancer. Oncotarget 8(58), 98918–98930 (2017).
MedlineGoogle Scholar
85. Zhao J, Lee EE, Kim J et al. Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus. Nat. Commun. 10(1), 2300 (2019).
MedlineGoogle Scholar
86. Hu C, Liu T, Han C et al. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m(6)A-MYC expression. Int. J. Biol. Sci. 18(2), 507–521 (2022).
Medline CASGoogle Scholar
87. Wang L, Zhan G, Maimaitiyiming Y et al. m(6)A modification confers thermal vulnerability to HPV E7 oncotranscripts via reverse regulation of its reader protein IGF2BP1 upon heat stress. Cell Rep. 41(4), 111546 (2022).
Medline CASGoogle Scholar
88. Churchill MJ, Deeks SG, Margolis DM, Siliciano RF, Swanstrom R. HIV reservoirs: what, where and how to target them. Nat. Rev. Microbiol. 14(1), 55–60 (2016).
Medline CASGoogle Scholar
89. Mendoza P, Gruell H, Nogueira L et al. Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature 561(7724), 479–484 (2018).
Medline CASGoogle Scholar
90. Lichinchi G, Gao S, Saletore Y et al. Dynamics of the human and viral m(6)A RNA methylomes during HIV-1 infection of T cells. Nat. Microbiol. 1, 16011 (2016).
Medline CASGoogle Scholar
91. Tirumuru N, Zhao BS, Lu W, Lu Z, He C, Wu L. N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression. Elife 5, e15528 (2016).
MedlineGoogle Scholar
92. Kennedy EM, Bogerd HP, Kornepati AVR et al. Posttranscriptional m(6)A Editing of HIV-1 mRNAs Enhances Viral Gene Expression. Cell Host Microbe 22(6), 830 (2017).
Medline CASGoogle Scholar
93. Tsai K, Bogerd HP, Kennedy EM, Emery A, Swanstrom R, Cullen BR. Epitranscriptomic addition of m(6)A regulates HIV-1 RNA stability and alternative splicing. Genes Dev. 35(13-14), 992–1004 (2021).
Medline CASGoogle Scholar
94. N'da Konan S, Segeral E, Bejjani F et al. YTHDC1 regulates distinct post-integration steps of HIV-1 replication and is important for viral infectivity. Retrovirology 19(1), 4 (2022). • Cytoplasmic readers of the m6A mark are recruited to the modified viral RNAs and regulate HIV-1 replication.
MedlineGoogle Scholar
95. Pereira-Montecinos C, Toro-Ascuy D, Ananias-Saez C et al. Epitranscriptomic regulation of HIV-1 full-length RNA packaging. Nucleic Acids Res. 50(4), 2302–2318 (2022).
Medline CASGoogle Scholar
96. Chen S, Kumar S, Espada CE et al. N6-methyladenosine modification of HIV-1 RNA suppresses type-I interferon induction in differentiated monocytic cells and primary macrophages. PLoS Pathog. 17(3), e1009421 (2021).
Medline CASGoogle Scholar
97. Lu W, Tirumuru N, St Gelais C et al. N(6)-Methyladenosine-binding proteins suppress HIV-1 infectivity and viral production. J. Biol. Chem. 293(34), 12992–13005 (2018).
Medline CASGoogle Scholar
98. Yankova E, Blackaby W, Albertella M et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature 593(7860), 597–601 (2021).
Medline CASGoogle Scholar

Vol. 18, No. 12

Metrics

Downloaded 28 times

History

Received 19 November 2022

Accepted 17 August 2023

Published online 5 September 2023

Published in print August 2023

Information

Keywords

Author contributions

Writing-original draft preparation, J Sun; writing-review and editing, Y Zhang and B Luo. All authors have read and agreed to the published version of the manuscript.

Financial & competing interest disclosure

This work was supported by Natural Science Foundation of Shandong Province (ZR2020MH302; ZR2020MC020); Qingdao Science and Technology Benefit the People Demonstration and Guidance Special Project (20-3-4-35-nsh). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

PDF download

N6-methyladenosine methylation of viral genes

Abstract

Plain language summary

References